Physicochemical characterization of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>3</sub>O, a new and promising agent for the treatment of hyperphosphatemia
The synthesis of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>2</sub>O was carefully investigated, on the basis of the thermal behavior (TG and DTA measurements) of the corresponding octahydrate, used as the precursor. The analysis of the X-ray po...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/8111 http://www.latamjpharm.org/resumenes/30/1/LAJOP_30_1_1_19.pdf |
| Aporte de: |
| Sumario: | The synthesis of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>2</sub>O was carefully investigated, on the basis of the thermal behavior (TG and DTA measurements) of the corresponding octahydrate, used as the precursor. The analysis of the X-ray powder diagrams of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>2</sub>O showed that this hydrate crystallizes in the tetragonal crystal system with Z = 8. The FTIR and FT-Raman spectra of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>2</sub>O and of La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub>.4H<sub>2</sub>O were recorded and assigned. The usefulness of the tetrahydrate for the treatment of hyperphosphatemia is briefly discussed. |
|---|